ACTIVITÉ PHOSPHOLIPASE A2 LYSOSOMALE (LPLA2) EN TANT QUE CIBLE DIAGNOSTIQUE ET THÉRAPEUTIQUE POUR IDENTIFIER ET TRAITER LE LUPUS ÉRYTHÉMATEUX DISSÉMINÉ

• 收藏
• 分享

专利权人:

THE REGENTS OF THE UNIVERSITY OF MICHIGAN

发明人:

申请号：

EP09774345.4

公开号：

EP2318036B1

申请日:

2009.06.30

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

The present invention is directed to methods for diagnosis and treatment of systemic lupus erythematosus and drug-induced systemic lupus erythematosus. More specifically, the specification describes methods using a lysosomal phospholipase A2 in methods for the diagnosis and treatment of autoimmune disorders such as systemic lupus erythematosus and drug-induced systemic lupus erythematosus.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/